Modotuximab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Modotuximab, covering 2020-01-14 to 2024-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer [Phase 3]